Uterine sarcoma in Geneva: a population based study

This study included 41(6%) patients with sarcoma and 401 (96%) patients with carcinoma. Compared with carcinoma, sarcoma patients were more often diagnosed before the age of 50 (22% versus 6%), had less often tumour confined to the uterine corpus(22% versus 78%), had less frequently radiotherapy (10% versus 51%), and more often chemotherapy (24% versus 3%)(Table 1). The 5-year overall survival was 76% for carcinoma and 34% for sarcoma (p<0.001)(Figure). After adjusting for age, tumour differentiation and stage at diagnosis, patients with sarcoma had significantly increased mortality risk (Hazard ratio: 3.6, 95% CI: